The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Pharmacol.
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 15 - 2024 |
doi: 10.3389/fphar.2024.1497524
This article is part of the Research Topic Probiotics and Their Metabolites in Cancer Therapy View all 6 articles
Editorial: Probiotics and Their Metabolites in Cancer Therapy
Provisionally accepted- 1 Ardabil University of Medical Sciences, Ardabil, Iran
- 2 Urmia University of Medical Sciences, Urmia, Iran
- 3 University of Catania, Catania, Sicily, Italy
Keywords: Probiotics, Cancer, Gastrointestinal Tract, Digestion, Gut Microbiota
Received: 17 Sep 2024; Accepted: 30 Sep 2024.
Copyright: © 2024 Gholizadeh, Faghfouri, Furneri and Faghfuri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Elnaz Faghfuri, Ardabil University of Medical Sciences, Ardabil, Iran
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.